Cargando…

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia

Refractory functional dyspepsia (RFD) is diagnosed when symptoms persist for at least 6 months despite at least two medical treatments. No consensus treatment guidelines exist. The implicated causes of functional biliary dyspepsia are a narrowed cystic duct, Sphincter of Oddi dysfunction, microlithi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Sung Ill, Lee, Tae Hoon, Jeong, Seok, Kwon, Chang-Il, Koh, Dong Hee, Kim, Yoon Jae, Lee, Hye Sun, Do, Min-Young, Cho, Jae Hee, Lee, Dong Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181150/ https://www.ncbi.nlm.nih.gov/pubmed/35683573 http://dx.doi.org/10.3390/jcm11113190

Ejemplares similares

Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial
por: Hyun, Jong Jin, et al.
Publicado: (2015)

Litholytic agents as an alternative treatment modality in patients with biliary dyspepsia
por: Kim, Young Min, et al.
Publicado: (2020)

Developing a procedure to extract chenodeoxycholic acid and synthesize ursodeoxycholic acid from pig by-products
por: Kim, On You, et al.
Publicado: (2023)

Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study
por: Lee, Jae Min, et al.
Publicado: (2015)

Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice
por: Jang, Sung Ill, et al.
Publicado: (2019)

Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study
por: Lee, Jin, et al.
Publicado: (2022)

Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
por: Yan, Zhao-wei, et al.
Publicado: (2015)

Hypersenstivity to Acid in Ulcer-like Functional Dyspepsia
por: Son, Hee Jung, et al.
Publicado: (1997)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022)

Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice
por: Chung, Yoo-Ri, et al.
Publicado: (2017)

Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
por: Khosravi, Mohsen
Publicado: (2020)

Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
por: Brass, Eric P., et al.
Publicado: (2020)

Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid
por: Islam, Mahjabin, et al.
Publicado: (2021)

Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
por: Cui, Kaiyu, et al.
Publicado: (2023)

Direct Effect of Chenodeoxycholic Acid on Differentiation of Mouse Embryonic Stem Cells Cultured under Feeder-Free Culture Conditions
por: Park, Soon-Jung, et al.
Publicado: (2013)

Effect of Ursodeoxycholic Acid on the Biodistribution and Excretion of Technetium-99m Radiopharmaceuticals in Rat: A Potential Image Quality Enhancer
por: Han, Yeon-Hee, et al.
Publicado: (2021)

Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1α Protein and Its Target Genes
por: Moon, Yunwon, et al.
Publicado: (2015)

The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial
por: Kim, Bom-Taeck, et al.
Publicado: (2020)

Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial
por: Lee, Sang Hyub, et al.
Publicado: (2020)

Ursodeoxycholic Acid Induces Death Receptor-mediated Apoptosis in Prostate Cancer Cells
por: Lee, Won Sup, et al.
Publicado: (2017)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
por: Seo, Sang Hyun, et al.
Publicado: (2022)

Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
por: Kim, Eun-Kyung, et al.
Publicado: (2017)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
por: Cariou, Bertrand, et al.
Publicado: (2011)

Magnetic Compression Anastomosis for the Treatment of Post-Transplant Biliary Stricture
por: Jang, Sung Ill, et al.
Publicado: (2020)

Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
por: Huidekoper, Hidde H., et al.
Publicado: (2015)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

Influence of the gut microbiota on endometriosis: Potential role of chenodeoxycholic acid and its derivatives
por: Li, Yangshuo, et al.
Publicado: (2022)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Acid Dyspepsia
Publicado: (1905)

Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid
por: Polak, Yasmin, et al.
Publicado: (2021)

Efficacy Analysis of Suprapapillary versus Transpapillary Self-Expandable Metal Stents According to the Level of Obstruction in Malignant Extrahepatic Biliary Obstruction
por: Han, Sung Yong, et al.
Publicado: (2023)

Synthesis of ursodeoxycholic acid by electrochemical stereoselective reduction of 7-ketolithocholic acid in aprotic solvents
por: Shen, Jinxue, et al.
Publicado: (2021)

Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow
por: Chung, Jihwa, et al.
Publicado: (2015)

Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
por: Oh, Ah-Reum, et al.
Publicado: (2016)

Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study
por: Chang, Jong-In, et al.
Publicado: (2023)

Evaluation of the effect of chenodeoxycholic acid treatment on skeletal system findings in patients with cerebrotendinous xanthomatosis
por: Zübarioğlu, Tanyel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2kciuoi17eirh4v48032s7dgvm